NPI: 1225302128 · PERRIS, CA 92571 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/24/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/24/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 34,211 | $1.69M |
| 2019 | 41,966 | $1.92M |
| 2020 | 32,896 | $1.48M |
| 2021 | 35,770 | $1.42M |
| 2022 | 35,531 | $1.73M |
| 2023 | 38,625 | $1.99M |
| 2024 | 23,856 | $1.85M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 81,891 | 6,927 | $11.88M |
| A4657 | Syringe, with or without needle, each | 7,238 | 3,374 | $182K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 67,944 | 5,046 | $7K |
| J1756 | Injection, iron sucrose, 1 mg | 20,651 | 5,017 | $5K |
| J1270 | Injection, doxercalciferol, 1 mcg | 39,315 | 3,445 | $3K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,230 | 714 | $3K |
| 0250 | 10,697 | 752 | $2K | |
| 83970 | 2,538 | 2,241 | $781.30 | |
| 90661 | 13 | 13 | $442.20 | |
| 83540 | 1,561 | 1,456 | $100.90 | |
| G0008 | Administration of influenza virus vaccine | 117 | 115 | $30.00 |
| 83550 | 1,340 | 1,238 | $0.00 | |
| 82728 | 1,508 | 1,419 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 297 | 143 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,157 | 886 | $0.00 |
| 82746 | 66 | 66 | $0.00 | |
| 90747 | 25 | 24 | $0.00 | |
| 82607 | 62 | 62 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 62 | 62 | $0.00 |
| 90674 | 163 | 157 | $0.00 | |
| 85048 | 2,410 | 2,299 | $0.00 | |
| 85041 | 2,474 | 2,360 | $0.00 | |
| 90662 | 73 | 71 | $0.00 | |
| 82108 | 23 | 21 | $0.00 |